Company news

Celcuity Inc. news in 2024

Celcuity Inc.'s news releases, calls and decks from 2024, newest first.

View company

Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium

December 10, 2024

Celcuity Inc. Reports Third Quarter Financial Results and Provides Corporate Update

November 13, 2024

Celcuity Inc. To Present at Upcoming Stifel and Jefferies Investor Conferences

November 11, 2024

Celcuity Inc. Schedules Release of Third Quarter 2024 Financial Results and Webcast/Conference Call

November 6, 2024

Celcuity Inc. Reports Second Quarter Financial Results and Provides Corporate Update

August 13, 2024

Celcuity Inc. Schedules Release of Second Quarter 2024 Financial Results and Webcast/Conference Call

August 6, 2024

Celcuity To Participate in Jefferies Global Healthcare Conference

June 2, 2024

Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Treatment for HR+/HER2- Advanced Breast Cancer and Secures Approximately $62 Million Debt Financing

May 29, 2024

Celcuity Announces Pricing of Underwritten Common Stock Offering

May 29, 2024

Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate Update

May 14, 2024

Celcuity Inc. Schedules Release of First Quarter 2024 Financial Results and Webcast/Conference Call

May 7, 2024

Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

March 26, 2024

Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Webcast/Conference Call

March 19, 2024

Celcuity to Participate in Leerink Partners Global Biopharma Conference 2024

March 5, 2024

Celcuity to Participate in Cowen’s 44th Annual Health Care Conference

February 27, 2024

Celcuity Announces First Patient Dosed in Phase 1b/2 CELC-G-201 Clinical Trial of Gedatolisib for the Treatment of Metastatic Castration Resistant Prostate Cancer

February 21, 2024

Celcuity Appoints Eldon Mayer as Chief Commercial Officer

February 19, 2024

Calls in 2024

Decks in 2024